Back
Black Diamond Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
BDTX
Black Diamond Therapeutics
Last Price:
$2.19
Seasonality Move:
4.48%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight buying pressure.
Black Diamond Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Sell |
| 20-day SMA: | 2.45 | Sell |
| 50-day SMA: | 2.79 | Sell |
| 200-day SMA: | 4.63 | Sell |
| 8-day EMA: | 2.33 | Sell |
| 20-day EMA: | 2.47 | Sell |
| 50-day EMA: | 2.92 | Sell |
| 200-day EMA: | 3.95 | Sell |
Black Diamond Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 33.58 | Sell |
| Chaikin Money Flow: | 30126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.34 - 2.58) | Sell |
| Bollinger Bands (100): | (2.61 - 5.31) | Sell |
Black Diamond Therapeutics Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 2.19 while BDTX 8-day simple moving average is 2.39, which is a Sell signal.
-
The stock price of BDTX is 2.19 while Black Diamond Therapeutics 20-day SMA is 2.45, which makes it a Sell.
-
Black Diamond Therapeutics 50-day simple moving average is 2.79 while BDTX share price is 2.19, making it a Sell technically.
-
BDTX stock price is 2.19 and Black Diamond Therapeutics 200-day simple moving average is 4.63, creating a Sell signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
25
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a SellThe current Black Diamond Therapeutics [BDTX] share price is $2.19. The Score for BDTX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
123.9M
Price in USD:
2.19
Share Volume:
421.8K
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
2.09
Sell
25
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?The Black Diamond Therapeutics stock price is 2.19 USD today.
-
Will BDTX stock go up or go down?Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Black Diamond Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 2.19 while BDTX 8-day exponential moving average is 2.33, which is a Sell signal.
-
The stock price of BDTX is 2.19 while Black Diamond Therapeutics 20-day EMA is 2.47, which makes it a Sell.
-
Black Diamond Therapeutics 50-day exponential moving average is 2.92 while BDTX share price is 2.19, making it a Sell technically.
-
BDTX stock price is 2.19 and Black Diamond Therapeutics 200-day simple moving average is 3.95, creating a Sell signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
-
BDTX Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Black Diamond Therapeutics is a Sell
-
Black Diamond Therapeutics Relative Strength Index (RSI) is 33.58, which suggest Black Diamond Therapeutics is oversold
-
The Bollinger Bands (25) for Black Diamond Therapeutics is (2.34 - 2.58), which suggest Black Diamond Therapeutics is a Sell
-
The Bollinger Bands (100) for Black Diamond Therapeutics is (2.61 - 5.31), which suggest Black Diamond Therapeutics is a Sell
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.